In human hepatocellular carcinomas, the PD-L1+ neutrophils from patients effectively hinder T cell proliferation and activation through interacting with the ligand PD-1, but this process is partially prevented by blocking PD-L1. This evidence concerns the gene CD274 and hepatocellular carcinoma.